Medadvisor Ltd
ASX:MDR
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
AU |
Medadvisor Ltd
ASX:MDR
|
181.6m AUD | 1.6 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.9B USD | 12.2 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.9 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 3.8 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
12B AUD | 81.4 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 4 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
5B USD | 6.9 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 7.8 | ||
SE |
Sectra AB
STO:SECT B
|
44.4B SEK | 27.3 | ||
US |
Evolent Health Inc
NYSE:EVH
|
2.8B USD | 1.6 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.